<DOC>
	<DOC>NCT00130858</DOC>
	<brief_summary>Phase II Study to evaluate the response on two blocks of topotecan and carboplatin</brief_summary>
	<brief_title>a Multicenter Clinical Trial for the Treatment of Children and Adolescents With Soft Tissue Sarcoma Stage 4</brief_title>
	<detailed_description>Phase II study for patients with chemosensible soft tissue sarcoma stage IV in children and adolescents ; response according to RECIST criteria following two blocks of combination therapy consisting of Topotecan and carboplatin</detailed_description>
	<mesh_term>Sarcoma</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<mesh_term>Topotecan</mesh_term>
	<criteria>Soft tissue sarcoma chemosensible, stage IV age &lt; 21 measurable tumor lesions Lack of cooperation by the patient no willingness of followup examinations participation on another clinical trial at the same time death due to the sickness within four weeks</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>April 2009</verification_date>
	<keyword>Sarcoma, Soft Tissue</keyword>
</DOC>